{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:12:30Z","timestamp":1762431150505},"reference-count":58,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2177\/jsci.39.155","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:46:28Z","timestamp":1466124388000},"page":"155-163","source":"Crossref","is-referenced-by-count":4,"title":["Potential of specialized pro-resolving lipid mediators against rheumatic diseases"],"prefix":"10.2177","volume":"39","author":[{"given":"Kosaku","family":"MURAKAMI","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Serhan, C.N., et al.: Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. <i>Proc Natl Acad Sci U S A<\/i>. <b>81<\/b>: 5335-5339, 1984.","DOI":"10.1073\/pnas.81.17.5335"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Serhan, C.N.: Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. <i>J Thromb Haemost<\/i>. <b>7 Suppl 1<\/b>: 44-48, 1990.","DOI":"10.1111\/j.1538-7836.2009.03396.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Merched, A.J., et al.: Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. <i>FASEB J<\/i>. <b>22<\/b>: 3595-3606, 2008.","DOI":"10.1096\/fj.08-112201"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Spite, M., et al.: Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. <i>Nature<\/i>. <b>461<\/b>: 1287-1291, 2009.","DOI":"10.1038\/nature08541"},{"key":"5","unstructured":"5) Rees, D., et al.: Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. <i>Am J Clin Nutr<\/i>. <b>83<\/b>: 331-342, 2006."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Serhan, C.N., et al.: The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. <i>Semin Immunol<\/i>. <b>27<\/b>: 200-215, 2015.","DOI":"10.1016\/j.smim.2015.03.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Dalli, J., et al.: Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections. <i>Nat Med<\/i>. <b>21<\/b>: 1071-1075, 2015.","DOI":"10.1038\/nm.3911"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Arita, M., et al.: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. <i>J Exp Med<\/i>. <b>201<\/b>: 713-722, 2005.","DOI":"10.1084\/jem.20042031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Birnbaum, Y., et al.: Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. <i>Circulation<\/i>. <b>114<\/b>: 929-935, 2006.","DOI":"10.1161\/CIRCULATIONAHA.106.629907"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chiang, N., et al.: Infection regulates pro-resolving mediators that lower antibiotic requirements. <i>Nature<\/i>. <b>484<\/b>: 524-528, 2012.","DOI":"10.1038\/nature11042"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Morita, M., et al.: The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. <i>Cell<\/i>. <b>153<\/b>: 112-125, 2013.","DOI":"10.1016\/j.cell.2013.02.027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rajasagi, N.K., et al.: Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. <i>J Immunol<\/i>. <b>186<\/b>: 1735-1746, 2011.","DOI":"10.4049\/jimmunol.1003456"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Haworth, O., et al.: Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. <i>Nat Immunol<\/i>. <b>9<\/b>: 873-879, 2008.","DOI":"10.1038\/ni.1627"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rogerio, A.P., et al.: Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. <i>J Immunol<\/i>. <b>189<\/b>: 1983-1991, 2012.","DOI":"10.4049\/jimmunol.1101665"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sawada, Y., et al.: Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. <i>J Exp Med<\/i>. <b>212<\/b>: 1921-1930, 2015.","DOI":"10.1084\/jem.20150381"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Endo, J., Arita, M.: Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. <i>J Cardiol<\/i>. <b>67<\/b>: 22-27, 2016.","DOI":"10.1016\/j.jjcc.2015.08.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Klein, C.P., et al.: Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. <i>Neuropharmacology<\/i>. <b>86<\/b>: 57-66, 2014.","DOI":"10.1016\/j.neuropharm.2014.05.043"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yamashita, A., et al.: Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. <i>Sci Rep<\/i>. <b>3<\/b>: 3113, 2013.","DOI":"10.1038\/srep03113"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Markworth, J.F., et al.: Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. <i>Am J Physiol Regul Integr Comp Physiol<\/i>. <b>305<\/b>: R1281-1296, 2013.","DOI":"10.1152\/ajpregu.00128.2013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Im, D.S.: Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. <i>Prog Lipid Res<\/i>. <b>51<\/b>: 232-237, 2012.","DOI":"10.1016\/j.plipres.2012.02.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Bena, S., et al.: Annexin A1 interaction with the FPR2\/ALX receptor: identification of distinct domains and downstream associated signaling. <i>J Biol Chem<\/i>. <b>287<\/b>: 24690-24697, 2012.","DOI":"10.1074\/jbc.M112.377101"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Schmid, M., et al.: Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32. <i>J Immunol<\/i>. 2016.","DOI":"10.4049\/jimmunol.1501701"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Visser, A.W., et al.: Adiposity and hand osteoarthritis: the Netherlands Epidemiology of Obesity study. <i>Arthritis Res Ther<\/i>. <b>16<\/b>: R19, 2014.","DOI":"10.1186\/ar4447"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yusuf, E., et al.: Association between weight or body mass index and hand osteoarthritis: a systematic review. <i>Ann Rheum Dis<\/i>. <b>69<\/b>: 761-765, 2010.","DOI":"10.1136\/ard.2008.106930"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ioan-Facsinay, A., et al.: Adipocyte-derived lipids modulate CD4<sup>+<\/sup> T-cell function. <i>Eur J Immunol<\/i>. <b>43<\/b>: 1578-1587, 2013.","DOI":"10.1002\/eji.201243096"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Klein-Wieringa, I.R., et al.: Adipocytes modulate the phenotype of human macrophages through secreted lipids. <i>J Immunol<\/i>. <b>191<\/b>: 1356-1363, 2013.","DOI":"10.4049\/jimmunol.1203074"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hill, C.L., et al.: Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. <i>Ann Rheum Dis<\/i>. <b>75<\/b>: 23-29, 2016.","DOI":"10.1136\/annrheumdis-2014-207169"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Di Giuseppe, D., et al.: Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. <i>Ann Rheum Dis<\/i>. <b>73<\/b>: 1949-1953, 2014.","DOI":"10.1136\/annrheumdis-2013-203338"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Proudman, S.M., et al.: Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. <i>Ann Rheum Dis<\/i>. <b>74<\/b>: 89-95, 2015.","DOI":"10.1136\/annrheumdis-2013-204145"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kronke, G., et al.: 12\/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. <i>J Immunol<\/i>. <b>183<\/b>: 3383-3389, 2009.","DOI":"10.4049\/jimmunol.0900327"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Blaho, V.A., et al.: 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis. <i>J Immunol<\/i>. <b>186<\/b>: 3076-3084, 2011.","DOI":"10.4049\/jimmunol.1003473"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Jonasdottir, H.S., et al.: Detection and structural elucidation of esterified oxylipids in human synovial fluid by electrospray ionization-fourier transform ion-cyclotron mass spectrometry and liquid chromatography-ion trap-MS(3): detection of esterified hydroxylated docosapentaenoic acid containing phospholipids. <i>Anal Chem<\/i>. <b>85<\/b>: 6003-6010, 2013.","DOI":"10.1021\/ac400826z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lima-Garcia, J.F., et al.: The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. <i>Br J Pharmacol<\/i>. <b>164<\/b>: 278-293, 2011.","DOI":"10.1111\/j.1476-5381.2011.01345.x"},{"key":"34","unstructured":"34) Sodin-Semrl, S., et al.: Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. <i>Int J Immunopathol Pharmacol<\/i>. <b>17<\/b>: 145-156, 2004."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Odusanwo, O., et al.: Resolvin D1 prevents TNF-alpha-mediated disruption of salivary epithelial formation. <i>Am J Physiol Cell Physiol<\/i>. <b>302<\/b>: C1331-1345, 2012.","DOI":"10.1152\/ajpcell.00207.2011"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Leigh, N.J., et al.: Expression of resolvin D1 biosynthetic pathways in salivary epithelium. <i>J Dent Res<\/i>. <b>93<\/b>: 300-305, 2014.","DOI":"10.1177\/0022034513519108"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Nelson, J.W., et al.: ALX\/FPR2 receptor for RvD1 is expressed and functional in salivary glands. <i>Am J Physiol Cell Physiol<\/i>. <b>306<\/b>: C178-185, 2014.","DOI":"10.1152\/ajpcell.00284.2013"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kowal-Bielecka, O., et al.: Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. <i>Arthritis Rheum<\/i>. <b>52<\/b>: 3783-3791, 2005.","DOI":"10.1002\/art.21432"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Kowal-Bielecka, O., et al.: leukotrienes and lipoxins in scleroderma lung disease\u2013insights and potential therapeutic implications. <i>Nat Clin Pract Rheumatol<\/i>. <b>3<\/b>: 43-51, 2007.","DOI":"10.1038\/ncprheum0375"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Luangsay, S., et al.: Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. <i>J Immunol<\/i>. <b>183<\/b>: 6489-6499, 2009.","DOI":"10.4049\/jimmunol.0901037"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Martins, V., et al.: ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. <i>J Immunol<\/i>. <b>182<\/b>: 5374-5381, 2009.","DOI":"10.4049\/jimmunol.0802259"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Alvarez, A.M., et al.: Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions. <i>Arthritis Rheumatol<\/i>. <b>67<\/b>: 488-497, 2015.","DOI":"10.1002\/art.38934"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Norling, L.V., Perretti, M.: The role of omega-3 derived resolvins in arthritis. <i>Curr Opin Pharmacol<\/i>. <b>13<\/b>: 476-481, 2013.","DOI":"10.1016\/j.coph.2013.02.003"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Berg, V., et al.: Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin (21-157). <i>Arthritis Res Ther<\/i>. <b>12<\/b>: R228, 2010.","DOI":"10.1186\/ar3215"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Muruganandan, S., et al.: Role of chemerin\/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. <i>J Bone Miner Res<\/i>. <b>25<\/b>: 222-234, 2010.","DOI":"10.1359\/jbmr.091106"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kaneko, K., et al.: Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. <i>Arthritis Res Ther<\/i>. <b>13<\/b>: R158, 2011.","DOI":"10.1186\/ar3475"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Eisinger, K., et al.: Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. <i>Exp Mol Pathol<\/i>. <b>92<\/b>: 90-96, 2012.","DOI":"10.1016\/j.yexmp.2011.10.006"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Muruganandan, S., et al.: Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. <i>Stem Cells<\/i>. <b>31<\/b>: 2172-2182, 2013.","DOI":"10.1002\/stem.1450"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Gao, L., et al.: Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. <i>J Immunol<\/i>. <b>190<\/b>: 689-694, 2013.","DOI":"10.4049\/jimmunol.1103688"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Shao, W.H., et al.: Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. <i>J Immunol<\/i>. <b>176<\/b>: 6254-6261, 2006.","DOI":"10.4049\/jimmunol.176.10.6254"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Herrera, B.S., et al.: An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. <i>Br J Pharmacol<\/i>. <b>155<\/b>: 1214-1223, 2008.","DOI":"10.1038\/bjp.2008.367"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Xu, S., et al.: Regulation of TNFalpha and IL1beta in rheumatoid arthritis synovial fibroblasts by leukotriene B4. <i>Rheumatol Int<\/i>. <b>30<\/b>: 1183-1189, 2010.","DOI":"10.1007\/s00296-009-1125-y"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Dixit, N., et al.: Leukotriene B4 activates intracellular calcium and augments human osteoclastogenesis. <i>Arthritis Res Ther<\/i>. <b>16<\/b>: 496, 2014.","DOI":"10.1186\/s13075-014-0496-y"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Hansen, A.K., et al.: Human articular chondrocytes express functional leukotriene B4 receptors. <i>J Anat<\/i>. <b>226<\/b>: 268-277, 2015.","DOI":"10.1111\/joa.12275"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Lee, M.S., et al.: Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. <i>J Immunol<\/i>. <b>177<\/b>: 5585-5594, 2006.","DOI":"10.4049\/jimmunol.177.8.5585"},{"key":"56","unstructured":"56) Hashimoto, A., et al.: Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. <i>J Rheumatol<\/i>. <b>34<\/b>: 2144-2153, 2007."},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Koga, T., et al.: Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. <i>FEBS Lett<\/i>. <b>582<\/b>: 579-585, 2008.","DOI":"10.1016\/j.febslet.2008.01.022"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Satomura, K., et al.: Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes. <i>Mod Rheumatol<\/i>. <b>23<\/b>: 28-35, 2013.","DOI":"10.3109\/s10165-012-0630-0"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["Specialized pro-resolving lipid mediator\uff08SPM\uff09\u306b\u3088\u308b\u95a2\u7bc0\u708e\u304a\u3088\u3073\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u5236\u5fa1\u306e\u53ef\u80fd\u6027"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_155\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:31:55Z","timestamp":1498321915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_155\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.39.155","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}